Form4insider filings, from the source

SEC Form 4 · accession 0001127602-17-009395

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan J Main
Officer — EVP, CMC and Supply Operations
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 6:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2017M2,357—A37,557D
Common StockF1Feb 28, 2017M2,678—A40,235D
Common StockF1Feb 28, 2017M5,271—A45,506D
Common StockF1Feb 28, 2017M4,085—A49,591D
Common StockFeb 28, 2017F5,361$16.45D44,230D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 28, 2017M2,357D——Common Stock2,3570D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 28, 2017M2,678D——Common Stock2,6782,679D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 28, 2017M5,271D——Common Stock5,27110,543D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 28, 2017M4,085D——Common Stock4,08512,255D

Explanation of responses